Roche Corleen M. 4
4 · CG Oncology, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option
2024-01-24+492,920→ 492,920 totalExercise: $19.00Exp: 2034-01-10→ Common Stock (492,920 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the underlying shares on January 16, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter.